Hint mode is switched on Switch off

USANA Health Sciences, ordinary share
USNA, US90328M1071

Add a stock to WL
Choose all Reset all
USANA Health Sciences, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

  • Issuer
  • Full borrower / issuer name
    USANA Health Sciences, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Indicators

News

15/04/2026 USANA Schedules First Quarter 2026 Earnings Release and Conference Call
11/02/2026 USANA Health Sciences: That Jim Brown Stepped Down As The Company’s Chief Executive Officer And President, And That Kevin Guest, The Company’s Chairman Of The Board, Reassumed The Role Of Chief Executive Officer. At The Time Of The Initial 8k, The Compensation Committee Of The Board (the “compensation Committee”) Had Not Determined The Compensation Arrangements For Mr. Brown Or Mr. Guest. The Compensation Committee Has Now Determined These Arrangements And, In Accordance With Instruction 2 To Item 5.02 Of Form 8k, The Company Is Filing This Amendment No. 1 To (i) Disclose The Material Terms Of The Transition Agreement Entered Into Between The Company And Mr. Brown And File Such Agreement As An Exhibit Hereto, And (ii) To Disclose The Material Terms Of Mr. Guest’s Compensation In Connection With His Appointment As Chief Executive Officer. Except As Specifically Set Forth Herein, No Other Changes Are Being Made To The Initial Form 8k, Financial Statements And Exhibits
12/01/2026 USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook
08/01/2026 USANA Health Sciences: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
20/10/2025 USANA Updates the Timing of the Release of Third Quarter 2025 Earnings Release and Conference Call
All organization news

Holders

Industry Leaders

Registration is required to get access.